BRAINSTORM CELL THERAPUTC
BCLI
BCLI was delisted on the 17th of July, 2025.
22 hedge funds and large institutions have $3.93M invested in BRAINSTORM CELL THERAPUTC in 2016 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 9 closing their positions.
10% less capital invested
Capital invested by funds: $4.35M → $3.93M (-$418K)
21% less funds holding
Funds holding: 28 → 22 (-6)
67% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 9
67% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
+$23.5K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$14.5K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$12.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ARTA
A.R.T. Advisors
New York
|
-$60K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$50K |
| 3 |
SM
Sabby Management
Miami Beach,
Florida
|
-$38.5K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$32K |
| 5 |
LPL Financial
San Diego,
California
|
-$27K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
26
LPL Financial
San Diego,
California
| – | -$27K | -667 | Closed |
|
|
PCM
27
Penserra Capital Management
Orinda,
California
| – | -$13 | -332 | Closed |
|
28
Bank of Montreal
Toronto,
Ontario, Canada
| – | -$3K | -67 | Closed |
|
|
TRCT
29
Tower Research Capital (TRC)
New York
| – | -$3K | -67 | Closed |
|
|
AIG
30
American International Group
New York
| – | -$1K | -33 | Closed |
|
|
DOA
31
D'Orazio & Associates
Falls Church,
Virginia
| – | -$1K | -33 | Closed |
|
BCLI Hedge Fund Activity: Q2 2016 in Review
22 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in BRAINSTORM CELL THERAPUTC (BCLI) for Q2 2016, worth a combined $3.93M — down 9.6% from $4.35M a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of BCLI and 3 opened new positions — a net loss of 6 holders — while 3 trimmed existing stakes and 1 added.
The largest buyer was Bank of America, opening a new position worth an estimated $23.5K. The largest seller was A.R.T. Advisors, exiting entirely with an estimated $60K sold.
- 22 institutional investors held BRAINSTORM CELL THERAPUTC (BCLI) as of Q2 2016, down from 28 in Q1 2016.
- Funds reported $3.93M of BRAINSTORM CELL THERAPUTC stock for Q2 2016, down 9.6% quarter-over-quarter.
- 3 funds opened new BRAINSTORM CELL THERAPUTC positions in Q2 2016 and 9 closed out, a net change of -6 holders.
- The largest BRAINSTORM CELL THERAPUTC buyer in Q2 2016 was Bank of America, an estimated $23.5K added.
- The largest BRAINSTORM CELL THERAPUTC seller in Q2 2016 was A.R.T. Advisors, an estimated $60K sold.
Based on aggregated 13F filings for Q2 2016.